September is Prostate Cancer Aware... ( WASHINGTON Aug. 12 /- Han...)

September is Prostate Cancer Awareness Month

Date:8/12/2009

WASHINGTON, Aug. 12 /PRNewswire/ -- Hank Oprinski, the CEO at Capital Earnings & Research, is launching his nationwide tour to inform corporations, chambers of commerce, golfing communities, economic clubs, universities and other interested civic organizations about the dangers of Prostate Cancer.

What did all the following businessmen have in common?

Earl Woods (Father of Tiger Woods)

Merv Griffin (TV Producer)

Tom Witter (Dean/Witter/Reynolds)

Steve Ross (CEO of Time Warner)

They all died from Prostate Cancer and the list continues to grow!

This year in the United States, approximately 200,000 men will be diagnosed with the disease. That means a new case will occur every 2 minutes and 30 seconds. "I'm a prostate cancer survivor and live a relatively normal life. Let me explain how I deal with this disease," says Oprinski.

Invite him to your organization to offer his presentation on how he copes with prostate cancer, involves his family for support and continues to build a successful business while addressing some of the following topics:

A partner to help you through challenging times
Support groups, second opinions, getting to know your body
Control of your destiny and medical outcome
Never spoken of side-effects
Preventive ways to minimize your risk of prostate cancer

Oprinski finds that many organizations never consider a guest speaker for an event of this type. His self designed "Increased Awareness Programs" are aimed at educating co-workers, guests and local communities who want to demonstrate involvement, the key theme of professional courtesy.

"It's what's happening across th
'/>"/>

SOURCE Capital Earnings & Research
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
3. Mega Events in September Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
4. September: Time to Try Cholesterol-Free Soyfoods
5. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
6. AMN Healthcare Services to Host Analyst Day on Tuesday, September 18, 2007
7. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
8. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
9. West Coast Bank Will Sponsor the Doernbecher Freestyle on September 22, 2007
10. On September 7th Local Organizations Partner to Celebrate Healthy Steps
11. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide

Post Your Comments:

(Date:5/23/2012)... Karlstad University in Sweden shows that phthalates from PVC ... are substances suspected to cause asthma and allergies, as ... shows that children can ingest these softening agents with ... , Phthalates are a group of chemical compounds that ... common consumer goods such as toys, cleaning solvents, packaging, ...

(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...

(Date:5/23/2012)... the United Kingdom have determined that azithromycin, a ... be an effective treatment option for patients suffering ... that occurs in the majority of patients following ... cause of mortality after the first year following ... repeatedly rejects the transplanted lung tissue. The syndrome ...

(Date:5/22/2012)... for determining effectiveness of medical therapies, tests and ... studies compared with other western countries, states an ... Association Journal ). , Dr. Salim Yusuf, McMaster ... Dr. John Cairns, University of British Columbia, argue ... provide better financial support of clinical trials and ...

(Date:5/22/2012)... began last year when the U.S. Preventive Services Task ... prostate-cancer tests to healthy men continued this week when ... stuck to their guns, stating that a blood test ... test, causes more harm than good it leads ... , But many people simply don,t believe that the ...

Breaking Medicine News(10 mins):Health News:Phthalates in PVC floors taken up by the body in infants 2 Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2 Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2 Health News:Canada should significantly increase its funding of randomized clinical trials 2 Health News:Psychological Science explains uproar over prostate-cancer screenings 2

[0] Phthalates in PVC floors taken up by the body in infants [0] Study Offers Ways to Decrease Use of Restraints at Nursing Homes [0] Study shows antibiotic improves respiratory function in lung transplant patients [0] Canada should significantly increase its funding of randomized clinical trials [0] Psychological Science explains uproar over prostate-cancer screenings

... living microorganisms that have beneficial effects on human health, ... a diverse range of disorders. However, the ways in ... fully understood. One of the action mechanisms could be ... and adaptive immune responses. At present there is only ...

... a common clinical encounter. Complications of this pathology are ... of the foreign body, the presence of a perforation, ... the University Medical Center of Grenoble advocates the use ... the proximal tip of the foreign body where it ...

... Uterine Fibroid Embolization, WASHINGTON, March 18 ... interventional radiology treatment,for uterine fibroids, provides significant ... (FUS) treatment failed, according to a study,released ... 33rd Annual,Scientific Meeting in Washington, D.C. Primary ...

... Successfully Treats, Graft-Versus-Host Disease, WASHINGTON, March ... (GVHD) after bone marrow or cord blood,transplant is ... it is not always effective and failure results ... 15 patients who failed standard,treatment were given a ...

... A study presented today,at the Society of Interventional ... in the Atlanta metro area, only 18 percent ... were told about uterine,fibroid embolization (UFE), a minimally ... UFE is a safe, effective,established treatment that has ...

... Greenhill & Co., Inc.,(NYSE: GHL ), a leading ... join the Firm as a Managing Director. Mr.,Giaquinto, who ... Care,Group at Citigroup Global Markets, will focus on the ... 18 years covering health care companies as an,investment banker, ...

Other Medicine News:Health News:Do bacterial combinations result in enhanced cytokine production? No! 2 Health News:What should we do when esophageal perforation occurs? 2 Health News:UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed 2 Health News:UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed 3 Health News:New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants 2 Health News:New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants 3 Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 2 Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 3 Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 4

Do bacterial combinations result in enhanced cytokine production? No!What should we do when esophageal perforation occurs?UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists Michael A. Giaquinto to Join Greenhill as a Managing Director

(Date:5/23/2012)... -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today ... U.S. phase 2 clinical trial, T reatment with ... reater E fficacy T rial (TARGET-NTM), ... with non-tuberculous mycobacterial (NTM) lung disease. ... current NTM treatment recommendations, and no new drugs have ...

(Date:5/23/2012)... TriReme Medical, Inc. (TMI) today announced approval by the ... PTCA Catheter, indicated for treating the stenotic portion of ... Glider™ is the world,s only torqueable PTCA ... tip technology, Glider™ is designed to perform, even in ... an ultra short balloon length of 4mm designed for ...

(Date:5/23/2012)... Reportlinker.com announces that a new ... catalogue: Pharmaceuticals - ... http://www.reportlinker.com/p0191857/Pharmaceuticals---Global-Group-of-Eight-G8-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu ... Industry Guide is an essential resource for ... industry in each of the G8 (United ...

[0] Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease [0] TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter [0] Pharmaceuticals - Global Group of Eight (G8) Industry Guide

... Nektar,s Technology Enables First-Ever PEGylation of a Small Molecule with ... Demonstrated Therapeutic ... NKTR ) announced initial results today from a Phase ... activity in patients with refractory solid tumors. The study,also demonstrates ...

... N.J., May 16 Veridex, LLC announced today ... has commercially launched a new gene methylation test ... specificity of ,DNA,methylation, in prostate cancer, detecting the ... of DNA that occurs primarily in,cancer. Veridex is ...

Other Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5

Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings New Gene Methylation Test for Prostate Cancer Available

Inquire...

Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....

... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...

Medicine Products:

MONOJECT Yellow Stopper VACUETTE Blood Grouping tubes - Non-ridged (pull cap)VACUETTE Blood Grouping tubes - Ridged (safety screw cap)BD Vacutainer® SST™ Tubes - Glass

September is Prostate Cancer Aware...( WASHINGTON Aug. 12 /- Han...),Health